ROTE WILLIAM E. sold TVTX
February 3, 2026 · Form 4 insider transaction
ROTE WILLIAM E. sold 12,446 shares of Travere Therapeutics, Inc. at $32.87 per share, a transaction worth $409.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,446
Price
$32.87
Total value
$409.1K
InsiderROTE WILLIAM E.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 3, 2026
Filing dateFebruary 3, 2026
Shares owned after109,087
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 29, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.